Based on the core
enterprise - Shenzhen Zhijun Pharmaceutical Co., Ltd., with the
advantage of scientific research cooperation with Sichuan
Industrial Institute of Antibiotics, The Pharmaceutical Division
expands its product lines, promotes related supporting facilities
for the production of raw material drugs, builds integrated
industrial chain, and enters new fields when occasion arises.
Moreover, it speeds up in developing international market and
strives to become one of the top 20 pharmaceutical enterprises in
China in the following 5 years.
Shenzhen Zhijun Pharmaceutical Co., Ltd.possesses a modern
pharmaceutical R & D manufacturing base covering 45,000 square
meters with the investment of 228 million Yuan in the first phase.
Its total assets is over RMB 600 million Yuan, its annual sales
amount is more than 700 million Yuan, and its annual tax is over
100 million Yuan. As one of top 50 pharmaceutical enterprises in
China, Zhijun Pharmaceutical now has over 1000 employees. Zhijun
Pharmaceutical focuses on manufacturing drugs for respiratory
system and anti-inflammatory products. With strict quality
assurance and control system and powerful marketing and sales
network, Zhijun Pharmaceutical has taken the leading position in
market with Compound Codeine Phosphate Oral Solution and Cefuroxime
for Injection (Da Li Xin) against their rival products. Now Zhijun
Pharmaceutical is pursuing a global recognition by means of
business collaboration overseas.
Shenzhen Zhijun Pharmaceutical Trading Co., Ltd. owns the import
& export and wholesale rights for drugs with an annual sales
nearly 100 million Yuan. It is the sole raw material importer for
Methadone Project for AIDS Control and Prevention of Chinese Center
for Disease Control and Prevention under the Ministry of Health of
the People s Republic of China. The company mainly acts as the
agent of Zhijun Pharmaceutical for its product registration,
export, distribution and promotion. Presently, it has exported
pharmaceutical preparations to more than ten countries in Southeast
Asia and Africa. It is also the sole agent of Zhijun Pharmaceutical
for supplying pharmaceutical preparations and importing raw
materials from such countries as America, Italy, Korea and India.
Besides, it is the sole agent for importing pharmaceutical
preparations from Korea to supply in Chinese market.
Shenzhen Main Luck Pharmaceuticals Inc.s a joint venture
established by China (Shenzhen Zhijun Pharmaceutical Co., Ltd.),
Japan (Mercian Business Corp.) and Hong Kong (Main Life Co., Ltd.).
It is ranked as the second among anti-tumor producers in China. As
one of the earliest specialized manufactory of anti-tumor medicine
in China, it has been keeping over 30% business increasing rate
annually. Now, Main Luck Pharmaceuticals has provided a series of
key, new state-level products such as Pirarubicin, Aclarubicin and
Doxorubicin.
Sinopharm Medicine Holding Shenzhen Chinese Traditional Medicine
Co., Ltd.is a modern joint-stock enterprise in Chinese traditional
medicine specialized in R & D and manufacture of drug products
for pediatrics, gynae and the aged. It is involved in the
manufacturing and distribution of a series of high-quality drug
products such as Qingjie oral liquid, Qingbai Vaginal Lotion and
guanxindanshen capsule.
